Eribulin Mesylate and Subvenite

• Generic Name: eribulin
• Dosage Forms: n.a.
• Other Brand Names: Halaven

Treatment of metastatic breast cancer in patients who have previously received at least 2 chemotherapeutic regimens, including an anthracycline and a taxane, in either the adjuvant or metastatic setting.

There is no generally accepted standard of care for management of advanced and heavily pretreated anthracycline- and taxane-refractory metastatic breast cancer. Some clinicians recommend individualizing therapy based on factors such as patient’s disease stage and tumor type, performance status, quality of life, preferences, treatment history (e.g., toxicity), underlying medical conditions, and expected benefits and risks of each option.

• Generic Name: lamotrigine
• Dosage Forms: tablet
• Other Brand Names: Lamictal, Lamictal ODT, Lamictal XR, Subvenite, Lamictal, Lamictal ODT, Lamictal XR, Lamictal CD, LaMICtal Starter Kit, LaMICtal ODT Patient Titration Kit, LaMICtal XR Patient Titration Kit, LamoTRIgine Starter Kit, Subvenite Starter Kit

Subvenite is an anti-epileptic medication, also called an anticonvulsant.

Subvenite is used alone or with other medications to treat epileptic seizures in adults and children. This medicine is also used to delay mood episodes in adults with bipolar disorder (manic depression).

Immediate-release Subvenite can be used in children as young as 2 years old when it is given as part of a combination of seizure medications. However, this form should not be used as a single medication in a child or teenager who is younger than 16 years old.

Extended-release Subvenite is for use only in adults and children who are at least 13 years old.

Subvenite may also be used for purposes not listed in this medication guide.